ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Ultragenyx Pharmaceutical Inc clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 63 studies whose lead sponsor is Ultragenyx Pharmaceutical Inc. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 4, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Ultragenyx Pharmaceutical with Ionis Pharmaceuticals →

Pipeline: 2 programs

Each counted once: 2 with a study Ultragenyx Pharmaceutical Inc leads registered in the last two years.

  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Ultragenyx Pharmaceutical Inc’s own registered studies; Ultragenyx Pharmaceutical Inc’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Ultragenyx Pharmaceutical Inc’s studies test, most studies first; none is open now — 7 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

4 of Ultragenyx Pharmaceutical Inc’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. 2A
  11. 1S
  12. O
  13. N

Add all 4 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 63 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now610%Recruiting 4 · Enrolling by invitation 1 · Not yet recruiting 1
  • Under way, not recruiting1016%
  • Completed2743%
  • Stopped early1829%Terminated 16 · Withdrawn 2
  • Status unknown or other23%

Phase

Where

  • United States55
  • Canada22
  • Spain22
  • United Kingdom20
  • France14
  • Germany13

Over the years

  1. 11
  2. 12
  3. 13
  4. 14
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 620
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ultragenyx Pharmaceutical Inc.

  • Ultragenyx Pharmaceutical Inc
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    63 studies

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 →